Sunshine Biopharma Inc (SBFM)

[zeekhoe]

NEWS RELEASE FOR 6/26

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12142104

For Immediate Release
June 26, 2017

SUNSHINE BIOPHARMA RELEASES RESULTS OF INDEPENDENT VALUATION

Montreal, Quebec -- (ACCESSWIRE) -- Sunshine Biopharma Inc. (OTC Markets: SBFM) is a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer. The Company’s lead anticancer compound, Adva-27a, has proven effective at killing Multidrug Resistant Cancer cells including Pancreatic Cancer cells, Small-Cell Lung Cancer cells, Breast Cancer cells and Uterine Sarcoma cells (Results published in ANTICANCER RESEARCH, Volume 32, Pages 4423-4432, October 2012).

The Company today received the results of an independent valuation it had commissioned on its issued and outstanding shares. MNP LLP (“MNP”) was retained to provide a Valuation Report (the “Report”), on the estimated en bloc Fair Market Value at March 31, 2017 (the “Valuation Date”), of its issued and outstanding shares. At the Valuation Date the value arrived at in the Report was in the range of $977.0 million to $1,133.0 million. The Company had commissioned the Report as part of an obligation it had previously made to investors.

MNP is one of the largest public accountancy firms in Canada (www.mnp.ca). The Montréal Valuation Practice (the “Practice”) is engaged in the valuation of businesses, business ownership interests, and securities and intangible assets in connection with business combinations, distributions of listed and unlisted securities, private placements, exchanges of shares, corporate and financial reorganizations, going-private transactions, leveraged buy-outs, fair value measurement of assets and liabilities for purchase price allocation and annual impairment testing for financial reporting pursuant to generally-accepted accounting principles both in Canada and the United States. The Practice has performed more than 3,000 valuations of public and private companies throughout Canada and in the United States during the past thirty years. Members of the Practice have also been playing an active role in the Canadian and U.S. professional societies of which they are accredited members, including serving on governing boards and standards-promulgating committees.

MNP is not an insider, associate, or affiliate of our Company or any of our affiliates, associates, or shareholders (collectively, the “Interested Parties”). MNP does not own shares in the Company, nor does it have any agreements, commitments, or undertakings in respect of any future business involving any of the Interested Parties. MNP’s professional fees for services rendered in preparing the Report were not contingent, in whole or in part, on the conclusions reached therein and were based strictly on the professional time expended on the engagement at their standard hourly rates.